ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2,1,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
4,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
4,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4,5,Headache,Headaches NEC,Headaches,Nerv,N
4,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
5,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
5,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5,4,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
5,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
6,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
7,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
7,2,Tracheal fistula,Tracheal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
7,3,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
8,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
9,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
9,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
9,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
10,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
10,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
10,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
11,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
11,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
11,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
11,8,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
11,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
13,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
13,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
13,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
13,4,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
13,5,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
13,6,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
13,7,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
14,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
14,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
15,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
15,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
16,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
16,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
17,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
18,1,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
19,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
19,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
19,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
19,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
19,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
20,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
21,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
21,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
22,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
22,2,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
23,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
24,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
24,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
25,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
25,2,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
25,3,Hepatic artery embolism,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
25,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
25,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
25,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
25,7,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
25,8,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
25,9,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
26,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
27,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,2,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
28,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
28,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,3,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
28,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
29,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
29,2,Pericardial effusion malignant,Pericardial disorders NEC,Pericardial disorders,Card,N
29,3,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
30,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
30,2,Pericardial effusion malignant,Pericardial disorders NEC,Pericardial disorders,Card,N
30,3,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
31,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
31,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
31,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
32,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
32,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
32,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
32,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
32,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
32,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
32,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
32,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
32,9,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
32,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
33,3,Headache,Headaches NEC,Headaches,Nerv,N
33,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
33,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
33,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
34,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
34,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
35,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
35,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
35,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
35,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
36,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
36,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
36,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
36,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
36,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
36,6,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
36,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
36,8,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
36,9,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
36,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
37,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
38,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
38,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
38,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
38,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,5,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
38,6,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
38,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
38,8,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
38,9,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
38,10,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
38,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
38,12,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,13,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
38,14,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,15,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
38,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
39,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
39,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
39,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
39,5,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
39,6,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
39,7,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
39,8,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
39,9,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
39,10,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
39,11,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
39,12,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
39,13,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
39,14,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
39,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
39,16,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
39,17,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
39,18,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
39,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,1,Headache,Headaches NEC,Headaches,Nerv,N
41,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
41,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
41,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
41,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
41,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
41,7,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
42,1,Glomerulonephritis membranoproliferative,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
42,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
43,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
44,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
45,1,Nasal septum perforation,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
45,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
46,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
46,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
46,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
47,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
47,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
48,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
48,2,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
48,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
49,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
49,2,Eastern Cooperative Oncology Group performance status worsened,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
49,3,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
49,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
49,5,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
49,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
50,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
50,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
51,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
52,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
52,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
52,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
53,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
54,1,Tongue geographic,Tongue disorders,Tongue conditions,Gastr,N
55,1,Tongue geographic,Tongue disorders,Tongue conditions,Gastr,N
56,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
56,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
57,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
57,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
58,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
58,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
58,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
59,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
60,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
61,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
62,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
62,2,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
63,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
63,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
64,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
64,2,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
64,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
64,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
64,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
64,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
64,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
64,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,9,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
65,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
66,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
67,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
68,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
69,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
70,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
70,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
70,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
70,4,Prothrombin level increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
71,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
72,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
72,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
72,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
73,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
73,2,Uterine perforation,Reproductive tract and breast procedural complications,Procedural related injuries and complications NEC,Inj&P,N
74,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
74,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
75,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
76,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
77,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
77,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
77,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
77,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
77,5,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
78,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
78,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
78,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
78,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
79,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
79,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
79,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
79,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
80,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
80,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
81,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
81,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
82,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
82,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
82,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
83,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
83,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
84,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
84,2,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
84,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
84,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
84,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,6,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
85,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
86,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
87,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
87,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
87,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
88,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
88,2,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
88,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
89,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
89,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
89,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
90,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
90,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
90,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
90,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
90,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
90,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
92,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
93,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
94,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
94,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
94,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
94,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
96,1,Chondronecrosis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
96,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
96,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
96,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
96,5,Tracheal fistula,Tracheal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
97,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
98,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
98,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
98,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
98,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
99,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
99,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
99,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
100,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
100,2,Headache,Headaches NEC,Headaches,Nerv,N
100,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
101,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
101,2,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
101,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
101,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
102,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
103,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
103,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
103,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
104,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
104,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
104,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
104,5,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
104,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
105,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
106,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
106,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
106,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
107,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
107,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
107,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
107,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
107,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
107,6,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
107,7,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
107,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
107,9,Lymphatic fistula,Lymphangiopathies,Lymphatic vessel disorders,Vasc,N
107,10,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
107,11,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
107,12,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
107,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
107,14,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
107,15,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
108,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
108,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
108,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
108,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
109,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
109,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
109,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
109,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
109,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
111,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
111,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
112,1,Female genital tract fistula,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
112,2,Urogenital fistula,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
113,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
113,2,Cardiac dysfunction,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
113,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
113,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
114,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
114,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
114,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
114,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
114,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
114,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
115,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
115,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
115,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
116,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
116,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
117,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
118,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
118,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
119,1,Headache,Headaches NEC,Headaches,Nerv,N
119,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
120,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
120,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
121,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
122,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
123,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
124,1,Headache,Headaches NEC,Headaches,Nerv,N
124,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
125,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
126,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
127,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
127,2,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
127,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
128,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
128,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
129,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
130,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
131,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
132,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
133,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
134,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
134,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
134,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
134,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
134,5,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
134,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
135,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
136,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
136,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
137,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
138,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
139,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
140,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
141,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
142,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
143,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
144,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
144,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
144,3,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
145,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
145,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
146,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
147,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
148,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
149,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
149,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
149,3,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
150,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
150,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
150,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
151,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
151,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
152,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
152,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
153,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
153,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
153,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
153,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,1,Headache,Headaches NEC,Headaches,Nerv,N
154,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
155,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
156,1,Brain natriuretic peptide increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
156,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
156,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
157,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
158,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
159,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
160,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
161,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
161,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
162,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
162,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
163,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
163,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
163,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
164,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
164,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
165,1,Rotator cuff syndrome,Joint related disorders NEC,Joint disorders,Musc,N
166,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
167,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
167,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
167,3,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
167,4,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
168,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
169,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
169,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
169,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
170,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
170,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
170,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
170,4,Portal tract inflammation,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
171,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
171,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
172,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
172,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
172,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
173,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
173,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
174,1,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
174,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
174,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
175,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
176,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
177,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
178,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
178,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
179,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
180,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
181,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
182,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
182,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
182,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
183,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
183,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
184,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
185,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
185,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
185,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
185,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
185,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
186,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
186,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
187,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
188,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
188,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
189,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
190,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
191,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
191,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
192,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
192,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
192,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
192,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
193,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
193,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
194,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
195,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
195,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
196,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
197,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
198,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
198,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
199,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
199,2,Gastrointestinal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
199,3,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
200,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
200,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
201,2,Gastrointestinal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
201,3,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
202,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
203,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
204,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
204,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
204,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
204,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
205,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
205,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
206,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
206,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
207,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
207,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
208,1,Liver function test decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
209,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
209,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
210,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
210,2,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
210,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
210,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
210,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
211,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
211,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
211,3,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
211,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
211,5,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
211,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
212,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
212,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
212,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
212,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
212,5,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
212,6,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
213,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
213,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
215,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
215,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
215,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
215,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
215,5,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
215,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
216,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
217,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
218,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
218,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
218,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
218,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
219,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
219,2,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
220,1,Migraine,Migraine headaches,Headaches,Nerv,N
221,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
221,3,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
222,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
223,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
224,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
224,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
224,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
224,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
224,5,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
224,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
224,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
224,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
225,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
225,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
225,3,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
225,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
226,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
226,2,Perforation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
226,3,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
226,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
226,5,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
227,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
228,1,Cold dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
228,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
228,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
228,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
228,5,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
228,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
228,7,Oral toxicity,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
228,8,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
228,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
229,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
230,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
231,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
231,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
232,1,Cold dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
232,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
232,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
232,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
232,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
232,6,Oral toxicity,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
232,7,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
233,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
234,1,Migraine,Migraine headaches,Headaches,Nerv,N
235,1,Migraine,Migraine headaches,Headaches,Nerv,N
236,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
237,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
238,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
239,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
239,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
239,3,Headache,Headaches NEC,Headaches,Nerv,N
239,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
239,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
240,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
240,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
240,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
241,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
241,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
242,1,Central venous catheterisation,Venous therapeutic procedures,Vascular therapeutic procedures,Surg,N
242,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
243,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
243,2,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
243,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
243,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
243,5,Headache,Headaches NEC,Headaches,Nerv,N
243,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
243,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
243,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
243,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
243,10,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
243,11,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
243,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
244,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
244,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
244,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
244,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
244,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
244,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
244,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
